JSE improves on US approval of Pfizer vaccine
Stocks also rallied on expectations that US Fed chair Jerome Powell will not trigger a taper tantrum
24 August 2021 - 11:33
The JSE was firmer on Tuesday morning, along with its global peers as concerns ease over the potential reduction in US monetary stimulus ease, while the US vaccination drive added to sentiment.
The Covid-19 vaccine made by Pfizer and BioNTech was granted full approval by US regulators, a milestone expected to help bolster the immunisation drive amid a renewed surge in infections driven by the Delta strain. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.